355 related articles for article (PubMed ID: 33197449)
1. Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile.
Pu M; Cho JM; Cunningham SA; Behera GK; Becker S; Amjad T; Greenwood-Quaintance KE; Mendes-Soares H; Jones-Hall Y; Jeraldo PR; Chen J; Dunny G; Patel R; Kashyap PC
Gastroenterology; 2021 Feb; 160(3):941-945.e8. PubMed ID: 33197449
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
Kolte B; Nübel U
J Antimicrob Chemother; 2024 Jun; 79(6):1320-1328. PubMed ID: 38598696
[TBL] [Abstract][Full Text] [Related]
3. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance in Clostridioides difficile.
O'Grady K; Knight DR; Riley TV
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
[TBL] [Abstract][Full Text] [Related]
5. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin.
Darkoh C; Keita K; Odo C; Oyaro M; Brown EL; Arias CA; Hanson BM; DuPont HL
Clin Infect Dis; 2022 Jan; 74(1):120-126. PubMed ID: 35016207
[TBL] [Abstract][Full Text] [Related]
7. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
Cizek A; Masarikova M; Mares J; Brajerova M; Krutova M
Microbiol Spectr; 2022 Aug; 10(4):e0080622. PubMed ID: 35950844
[TBL] [Abstract][Full Text] [Related]
8. Progress on mechanisms of antibiotic resistance in Clostridioides difficile.
Teng X; Hai-Hui H
Yi Chuan; 2023 Nov; 45(11):1028-1038. PubMed ID: 38764268
[TBL] [Abstract][Full Text] [Related]
9. Diversity of Circulating
Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
[No Abstract] [Full Text] [Related]
12. The
Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
[TBL] [Abstract][Full Text] [Related]
13. Plasmid-mediated metronidazole resistance in Clostridioides difficile.
Boekhoud IM; Hornung BVH; Sevilla E; Harmanus C; Bos-Sanders IMJG; Terveer EM; Bolea R; Corver J; Kuijper EJ; Smits WK
Nat Commun; 2020 Jan; 11(1):598. PubMed ID: 32001686
[TBL] [Abstract][Full Text] [Related]
14. Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin Susceptibility.
Greentree DH; Rice LB; Donskey CJ
Clin Infect Dis; 2022 Oct; 75(9):1661-1664. PubMed ID: 35653393
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in
Imwattana K; Knight DR; Kullin B; Collins DA; Putsathit P; Kiratisin P; Riley TV
Expert Rev Anti Infect Ther; 2020 Jan; 18(1):17-25. PubMed ID: 31800331
[No Abstract] [Full Text] [Related]
16. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
Abutaleb NS; Seleem MN
Sci Rep; 2020 May; 10(1):7701. PubMed ID: 32382070
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.
van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA
J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573
[TBL] [Abstract][Full Text] [Related]
18. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
Phanchana M; Phetruen T; Harnvoravongchai P; Raksat P; Ounjai P; Chankhamhaengdecha S; Janvilisri T
Sci Rep; 2020 Apr; 10(1):6497. PubMed ID: 32300130
[TBL] [Abstract][Full Text] [Related]
19. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.
Warren CA; van Opstal E; Ballard TE; Kennedy A; Wang X; Riggins M; Olekhnovich I; Warthan M; Kolling GL; Guerrant RL; Macdonald TL; Hoffman PS
Antimicrob Agents Chemother; 2012 Aug; 56(8):4103-11. PubMed ID: 22585229
[TBL] [Abstract][Full Text] [Related]
20. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.
Tickler IA; Goering RV; Whitmore JD; Lynn AN; Persing DH; Tenover FC;
Antimicrob Agents Chemother; 2014 Jul; 58(7):4214-8. PubMed ID: 24752264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
